NeoGenomics

NeoGenomics is a leading cancer diagnostics and pharmaceutical services company, providing innovative diagnostic, prognostic, and predictive testing for oncologists, pathologists, pharmaceutical companies, academic centers, and others. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-licensed facilities across the United States, but we strive to maintain the accessibility and efficiency of smaller operations.